{"id":"W2903866675","doi":"10.1016/j.msard.2018.10.105","title":"Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Opera; Multiple sclerosis; Clinical trial; Internal medicine; Surgery; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009098953,0.0002941944,0.0008353509,0.0003287356,0.0003840769,0.0004754256,0.0002600835,0.0005261094,0.0007771567],"category_scores_gemma":[0.001817088,0.0001052301,0.0008744794,0.0002925902,0.0001798892,0.0004027942,0.0002868866,0.0007044778,0.0001492105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003364787,"about_ca_system_score_gemma":0.000391073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002027791,"about_ca_topic_score_gemma":0.002801832,"domain_scores_codex":[0.9995529,0.0001072333,0.00005572344,0.00007747774,0.00008512942,0.000121555],"domain_scores_gemma":[0.9989976,0.0002263054,0.000362054,0.00006249313,0.0001150203,0.0002365232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03919004,0.001885976,0.8825483,0.0002546145,0.001251334,0.0005938393,0.0004802304,0.0007751369,0.004011395,0.00006940623,0.0005354724,0.06840424],"study_design_scores_gemma":[0.0003365062,0.004600934,0.9931008,0.00002334241,0.0004396407,0.0003209812,0.0001134464,0.000408951,0.0002441526,0.00003204479,0.0003648032,0.0000145214],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980433,0.001378623,0.00003516043,0.00004277924,0.00001464608,0.00000796071,0.00009523339,0.000006007529,0.0003763573],"genre_scores_gemma":[0.999545,0.0001250937,0.00002243283,0.00002197866,0.00001163442,0.000005473333,0.0001359452,6.760072e-7,0.000131616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002027791,"threshold_uncertainty_score":0.004812062,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01277753586088721,"score_gpt":0.2321336456996975,"score_spread":0.2193561098388103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}